Management of pregnancy-associated acute leukemia

Since leukocystosis and anemia are common findings in pregnancy, pathological alterations in hematopoesis, such as leukemias, can sometimes proceed undetected. Chemotherapy during pregnancy carries the risk of teratogenic effects on the fetus, and there is little data to guide chemotherapeutic regim...

Full description

Saved in:
Bibliographic Details
Published inEuropean journal of gynaecological oncology Vol. 24; no. 3-4; p. 251
Main Authors Su, W L, Liu, J Y, Kao, W Y
Format Journal Article
LanguageEnglish
Published Italy 2003
Subjects
Abortion, Therapeutic
Adult
Antineoplastic Combined Chemotherapy Protocols - therapeutic use
Cesarean Section
Female
Follow-Up Studies
Gestational Age
Humans
Leukemia, Myeloid, Acute - diagnosis
Leukemia, Myeloid, Acute - drug therapy
Parity
Pregnancy
Pregnancy Complications, Neoplastic - diagnosis
Pregnancy Complications, Neoplastic - drug therapy
Pregnancy Outcome
Pregnancy, High-Risk
Risk Assessment
Severity of Illness Index
Online AccessGet more information

Cover

More Information
Summary:Since leukocystosis and anemia are common findings in pregnancy, pathological alterations in hematopoesis, such as leukemias, can sometimes proceed undetected. Chemotherapy during pregnancy carries the risk of teratogenic effects on the fetus, and there is little data to guide chemotherapeutic regimens for leukemia during pregnancy. The following paper describes our experience in treating two women with acute leukemia during pregnancy and the immediate postpartum period, and reviews the relevant literature.
ISSN:0392-2936